During ABX monotherapy, both biomarkers had exhibited an increasing trend ( 17 ).
← all excerpts
Exploring the long-term use of ambroxol in Gaucher disease type 2: insights from two pediatric cases.
1
—
—
During ABX monotherapy, both biomarkers had exhibited an increasing trend ( 17 ).